Tuesday, August 4, 2020

As India fights coronavirus, it must ensure equitable access to tests

A government's response to the pandemic should be based on public health science, which thrives on scrutiny and debate, writes Dr Chandrakant Lahariya.


India reported its first case of COVID-19 on January 30. Six months later, more cases are being reported than ever on nearly every day, and India’s case-load curve has stayed stubbornly on the rise.
The collective strategy to ‘test, trace, treat’ has formed the bedrock of most governments’ response to the pandemic. India has been ramping up testing, implementing ‘trace’ in the form of contact tracing, and scaling up treatment services through additional beds--in ICUs with and without ventilators, in hospitals with and without oxygen, and in isolation facilities.

But on July 31, India had had nearly 1.7 million cumulative cases, 57,000 new cases and 36,500 cumulative deaths. Of course, the absolute number of cases is not a good way to measure an evolving pandemic; we need more nuanced approaches and indicators.

New parameters

Every stage of a pandemic requires its own set of indicators to suitably assess the situation and deploy interventions and supportive measures. Recovery rate and doubling rate were useful for the early stages, but are less so today. In similar vein, aiming to conduct a million COVID-19 tests every day may not always be the best use of our resources. We must instead focus our efforts on places where the outbreak seems to have become widespread.

A few weeks ago, in a press conference, then the officer on special duty in the health ministry and now union health secretary Rajesh Bhushan had said India has achieved the WHO suggested threshold of 140 tests per million population per day.


No comments:

Post a Comment